Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

80.11
Delayed Data
As of May 27
 -0.03 / -0.04%
Today’s Change
69.90
Today|||52-Week Range
106.84
-6.89%
Year-to-Date
3 Growth Stocks to Buy in June
8:10am / MotleyFool.com - Paid Partner Content
The Best Buys in Biopharma Today
May 24 / MotleyFool.com - Paid Partner Content
This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales
May 27 / MotleyFool.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
May 19 / MotleyFool.com - Paid Partner Content
PDL BioPharma Agrees to Equity Investment in Noden Pharma
May 25 / Zacks.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.14
Today’s open80.36
Day’s range79.99 - 80.38
Volume1,276,175
Average volume (3 months)2,366,133
Market cap$186.2B
Dividend yield3.39%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.04%
Revenue growth (last year)-4.75%
P/E ratio28.5
Price/Sales4.25
Price/Book2.47

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+9.50+1.14%
PFEPfizer+0.18+0.52%
MRKMerck+0.09+0.16%
BMYBristol-Myers Squibb+0.58+0.82%
Data as of 4:03pm ET, 05/27/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$1.21
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Partner Offers

Search for Jobs